In this retrospective cohort analysis of dually eligible beneficiaries, at-risk Medicare Advantage (MA) was associated with higher quality and avoidable health care utilization compared with both ...
Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...
Asad Adow admitted to fraudulently billing Housing Stabilization Services for millions in Medicaid reimbursement.
The Centers for Medicare & Medicaid Services (CMS) has issued new guidance for telehealth providers impacted by the government shutdown. | The CMS clarified that telehealth providers can submit any ...
Donald Trump has signed deals with the pharma giants Novo Nordisk and Eli Lilly to lower the prices of antiobesity drugs and get more US citizens taking them. The deal will cover tirzepatide (Lilly’s ...
Medicare Part B enrollees will pay at least $202.90 a month in 2026, up from the $185 monthly premium this year, according to ...
Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...
Texas Attorney General Ken Paxton filed a lawsuit Thursday on behalf of the state that takes aim at “false, misleading, and ...
In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...
The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life ...
A groundbreaking Karolinska Institutet study, published in The Lancet Regional Health – Europe, found that individuals ...
FOX 7 Austin on MSN
Texas earns 'D' on March of Dimes report as infant mortality worsens
Texas earned a "D" grade from the March of Dimes for its overall maternal and infant health outcomes, marking a deteriorating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback